Identification
Personal identification
- Full name
- Jacinta Serpa
- Date of birth
- 1974/04/03
- Gender
- Female
Citation names
- Serpa, Jacinta
Author identifiers
- Ciência ID
- 2610-7C0D-38F2
- ORCID iD
- 0000-0002-1548-5907
Knowledge fields
- Medical and Health Sciences - Clinical Medicine
- Natural sciences - Biological Sciences
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
French | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) | Intermediate (B1) |
Education
Degree | Classification | |
---|---|---|
2005
Concluded
|
Biologia Humana (Doutoramento)
Major in Sem especialidade
Universidade do Porto Faculdade de Medicina, Portugal
"Scretor and Lewis Phenotype / Genotype and Their Relevance for Helicobater Pylori Infection" (THESIS/DISSERTATION)
|
|
1997
Concluded
|
Biologia (Licenciatura)
Universidade dos Açores, Portugal
|
15 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2006/01/03 - Current | Researcher (Research) | Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal |
2000/01 - 2005/12 | Researcher (Research) | Universidade do Porto, Portugal |
1998/01 - 2000/12 | Researcher (Research) | Laboratório de Energia, Portugal |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2008/08/28 - Current | Assistant Professor (University Teacher) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
2016 - 2018 | Assistant Professor (University Teacher) | Universidade Nova de Lisboa, Portugal |
Positions / Appointments
Category Host institution |
Employer | |
---|---|---|
2013 - 2016 | Conselho científico/técnico-científico ou orgão correspondente | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
Projects
Contract
Designation | Funders | |
---|---|---|
2022/09/01 - 2026/08/31 | Role of DNA-dependent signaling loop in the regulation of cancer metabolism
NOSelf Project
Principal investigator
iNOVA4Health, Portugal
|
No Self Italy
Ongoing
|
2020/10/01 - 2023/09/30 | Urease Next-Generation Inhibition Therapy
PTDC/MED-QUI/3542/2020
Researcher
Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2021/06/01 - 2022/05/31 | Cystathionine-ß- synthase inhibition as a therapeutic approach in colorectal and lung cancer
SpeedGrant
Principal investigator
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
Merck KGaA
Ongoing
|
2018/10/01 - 2021/09/30 | Dendrimer-based Report-Eradication Antineoplasic Machines
PTDC/MEC-ONC/29327/2017
Researcher
|
|
2016/04/01 - 2019/03/31 | (per)Sulfidomics: benchmarking mechanisms underlying drug toxicity and drug resistance in precision medicine
iNOVA4Health- project 21
Researcher
|
|
2017/03/01 - 2019/02/28 | Targeting monocytes as angiogenesis promoters in cancer- New application for old drugs; Funded by iNOVA4Health, FCT
iNOVA4Health Project-35
Principal investigator
|
|
2015/03/01 - 2018/02/28 | Ovarian cancer (OC) a suitable model to define metabolic profile as a tool to predict chemoresistance
iNOVA4Health- project 4
Principal investigator
|
|
2015/04/01 - 2017/03/31 | Molecular mechanisms of cell migration and invasion: developing a new strategy to impair tumor progression
iNOVA4Health-project 6
PTDC\BIMMEC\4905\2014
Researcher
|
|
2014/04/01 - 2016/03/31 | Biomarcadores e potenciais alvos terapêuticos em carcinoma do colo uterino
Terry Fox 2014
Researcher
|
|
2013/04/01 - 2016/03/31 | Risco de Cancro Familiar e Individual – Identificação de Novos Genes
Projecto TVI
Researcher
|
|
2014/03/01 - 2016/02/28 | CarCHistonOmic
CQE/2014_031-IST-ID
Researcher
|
|
2013/05/01 - 2015/09/30 | Metaboloma do líquido cefalorraquidiano em doentes oncológicos
PTDC/BIM-ONC/1242/2012
Researcher
|
|
2011/04/01 - 2013/03/31 | Monocarboxylate transporters (MCTs) as putative therapeutic targets in acute myeloid leukaemia (AML)
Terry Fox 2011
Principal investigator
|
|
2011/04/01 - 2013/03/31 | Role of Lactate Rich Microenvironment in Uterine Cervix Cancer Progression
FLAD- 2011
Principal investigator
|
|
2007/04/01 - 2009/03/31 | Role of butyrate rich colon microenvironment in tumour progression
FLAD-2007
Researcher
|
|
2002/01/01 - 2005/12/31 | Characterization of gastric lesions associated with Helicobacter pylori infection in the workers of a shipyard from Viana
do Castelo
FC-54918
PhD Student Fellow
|
|
2002/10/01 - 2005/09/30 | egulation of aberrant MUC2 mucin gene expression in intestinal metaplasia, mucinous gastric carcinomas and gastric carcinoma
cell lines: role of methylation and putative transcription factors
POCTI/CBO/39075/2001
PhD Student Fellow
|
|
1999/03/01 - 2001/02/28 | Human fucosyltransferases: membrane organization and regulation of the in vivo activity
P/BIO/12072/98
Research Fellow
|
|
1998/06/01 - 2000/07/31 | Mucins in the pathophysiology of inflammatory diseases of the bronchial and gastrointestinal epithelia
BMH4-CT98-3222
Research Fellow
|
Outputs
Publications
Book chapter |
|
Conference paper |
|
Journal article |
|
Thesis / Dissertation |
|
Intellectual property
Provisional application for patent |
|
Other
Dataset |
|
Other output |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2012 | HDACS INHIBITORS EFFECTS IN OVARIAN CLEAR CELL CARCINOMA | Sinal 2012
(Póvoa do Varzim, Portugal)
|
2003 | Characterization and regulation of the 5’-flanking region of human MUC2 in gastric carcinoma cell lines | Mucins in Health and Disease – 7th International Workshop on Carcinoma-associated mucins
(Creta, Greece)
|
2003 | Modifications in the mucin expression profile in gastric carcinoma and intestinal metaplasia | Mucins in Health and Disease – 7th International Workshop on Carcinoma-associated mucins
(Creta, Greece)
|
2001 | Mucins: differentiation markers in intestinal metaplasia and gastric carcinoma | X Porto Cancer Meeting - Diagnosis of cancerous and precancerous lesions
(Porto, Portugal)
|
2000 | Expression of the recombinant Human alpha 3/4-Fucosyltransferase III using the baculovirus insect cell system. | Enzyme characterisation and substrate specificity. Congresso Nacional de Bioquímica
(Póvoa do Varzim, Portugal)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2021/02/01 - Current | Dendrimer nanotherapeutics: A novel anticancer task force
Co-supervisor
|
Associação para o Desenvolvimento do Instituto Superior Técnico, Portugal
|
2019 - Current | Cysteine availability rules thiols’ turnover and breast cancer chemoresistance
Supervisor
|
PhD (PhD)
Universidade Nova de Lisboa, Portugal
|
2017 - Current | Monocytes as neoangiogenesis promoters and anti-cancer targets
Supervisor
|
PhD (PhD)
Universidade Nova de Lisboa, Portugal
|
2022/09/01 - 2026/08/31 | Role of DNA-dependent signaling loop in the regulation of cancer metabolism
Supervisor
|
PhD (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2022/09/01 - 2026/08/31 | Understanding the role of melanin secretion on cutaneous melanoma invasion and response to immunotherapy
Co-supervisor
|
PhD (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2022/09/01 - 2026/08/31 | Use of a chronic intermittent hypoxia model to define the environmental cardiovascular risk associated with the aryl hydrocarbon
receptor
Co-supervisor
|
PhD (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2022/09/01 - 2026/08/31 | Oxidative modifications of human hydrogen sulfide-synthesizing enzymes in cancer chemoresistance
Co-supervisor
|
PhD (PhD)
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica António Xavier, Portugal
|
2021/09/01 - 2026/08/31 | Biomarkers in melanoma brain metastasis
Co-supervisor
|
PhD (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2023/11/20 - 2025/02/12 | Glucagon signalling and metabolic remodelling, a driving force of hepatocellular carcinoma (HCC)
Supervisor
|
Mestrado em Oncobiologia (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2023/09/01 - 2024/11/24 | Trigger ferroptosis in breast cancer (BC) cells by targeting xCT and FATP1
Supervisor
|
Mestrado Biologia Humana e Ambiente (Master)
Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
|
2023/09/01 - 2024/11/20 | Metabolic kinetics upon the exposure to glucagon in hepatocellular carcinoma (HCC)
Co-supervisor
|
Mestrado em Investigação Biomédica (Master)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2020/09/01 - 2024/11/17 | Targeting glutamine availability- a new strategy to treat malignant gliomas
Supervisor
|
Biomedicina (PhD)
Universidade Nova de Lisboa, Portugal
|
2023/09/01 - 2024/10/20 | Metabolic implosion - engineered nanotherapeutics for glioblastoma shutdown (GBMBs)
Supervisor
|
Mestrado de Investigação Biomédica (Master)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2019 - 2024/07/17 | MCT1 a peon in metabolic adaptation and a crucial target in lung cancer
Supervisor
|
PhD (PhD)
Universidade Nova de Lisboa, Portugal
|
2019 - 2024/02/05 | Tackling cancer chemoresistance by metabolic remodeling
Supervisor
|
PhD (PhD)
Universidade Nova de Lisboa, Portugal
|
2022/09/01 - 2023/11/20 | Impact of anti-CTLA4 and anti-PDL1 on the cross talk between cancer and immune cells, underlying CAT-VTE
Supervisor
|
Mestrado Biologia Humana e Ambiente (Master)
Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
|
2022/09/01 - 2023/11/14 | The role of glucagon: GCGR axis in pancreatic neuroendocrine tumours
Supervisor
|
Mestrado de Investigação Biomédica (Master)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2020/09/01 - 2021/11/18 | Metabolic and gene expression profiles related to EGFR mutations in lung cancer
Co-supervisor
|
MESTRADO EM MEDICINA E ONCOLOGIA MOLECULAR (Master)
Universidade do Porto, Portugal
|
2020/09/01 - 2021/11/17 | Unravelling the Pivotal Metabolic Pathways of Malignant Gliomas
Supervisor
|
Mestrado em Investigação biomédica (Master)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
2017/01/01 - 2021/04/21 | Novel mechanisms in angiogenesis: oxidative stress as a promoter of monocyte-to-endothelial cell differentiation and endothelial
cell activation
Supervisor
|
ProRegeM (PhD)
Universidade Nova de Lisboa Comprehensive Health Research Centre, Portugal
|
2012 - 2019/09/30 | Male breast cancer
Co-supervisor
|
PhD (PhD)
Universidade Nova de Lisboa, Portugal
|
2015 - 2019/04/02 | Cysteine degradation as a sulfur source to sustain oxidative phosphorylation (OXPHOS) in hypoxic cancer cells - new therapeutic
targets
Supervisor
|
PhD (PhD)
Universidade Nova de Lisboa, Portugal
|
2018 - 2019 | Metabolic remodeling of endothelial cells upon hypoxia
Supervisor
|
Mestrado (Master)
Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
|
2018 - 2019 | Cysteine metabolism and pancreatic Neuroendocrine Tumours (PNETs) chemoresistance
Supervisor
|
mestrado (Master)
Universidade Nova de Lisboa, Portugal
|
2018 - 2019 | xCT (SLC7A11)-Antiporter system role in ovarian carcinoma chemoresistance
Supervisor
|
mestrado (Master)
Università di Pisa Sistema Bibliotecario di Ateneo, Italy
|
2017 - 2018 | Disclosing FATP1 as a therapeutic target in breast cancer.
Supervisor
|
mestrado (Master)
Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
|
2017 - 2018 | Cysteine uptake capacity is a relevant mechanism of resistance to platinum salts, in ovarian cancer
Supervisor
|
mestrado (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2016 - 2017 | Clarification of ¿2 laminin role in cervical invasive carcinoma- a putative biomarker for disease outcome
Supervisor
|
mestrado (Master)
Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
|
2009 - 2017 | Biomarkers of sensitivity / resistance to new therapeutic targets: the use of histone deacetylases inhibitors in ovarian cancer
Co-supervisor
|
PhD (PhD) |
2013 - 2014 | Modulation of Acute Myeloide Leukemia (AML) metabolism by the Vascular Endothelial Growth Factor (VEGF)- in vitro study
Supervisor
|
mestrado (Master)
Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
|
2010 - 2014 | How tumor cells recognize and interact with endothelial cells in primary tumor and organs target of metastasis
Co-supervisor
|
PhD (PhD)
Universidade Nova de Lisboa, Portugal
|
2013 - 2013 | Gluconeogenesis and amino acids metabolism in ovarian clear cell carcinoma
Supervisor
|
MsC (Master)
Universidade do Algarve, Portugal
|
2012 - 2012 | Specific features of endothelial cells in primary tumors
Co-supervisor
|
PhD (PhD)
Universidade Nova de Lisboa, Portugal
|
2012 - 2012 | Lactate dehydrogenase A chain (LDHA) in Acute Myeloid Leukaemia (AML)
Supervisor
|
MsC (Master)
Universidade de Lisboa, Portugal
|
2011 - 2012 | Metabolic switch in uterine cervix cancer - in vitro study of adenocarcinoma (HeLa) and squamous cell carcinoma (SiHa) cell
lines
Supervisor
|
mestrado (Master)
Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
|
2011 - 2011 | Role of fibronectin (FN) in tumour development and progression
Supervisor
|
MsC (Master)
Universidade de Lisboa, Portugal
|
2008 - 2008 | Regulação da expressão de "Vascular endothelial growth factor" (VEGF) e do seu receptor 2 (KDR). Modificações pós-traducionais
de KDR
Supervisor
|
MsC (Master)
Universidade de Lisboa, Portugal
|
2007 - 2007 | Estudo de mutações somáticas no gene APC em doentes com cancro de colón e recto em idade jovem
Supervisor
|
MsC (Master)
Universidade de Lisboa, Portugal
|
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2013 - 2013 | VORINOSTAT INDUCES ARID1A SPLICING VARIANT EXPRESSION WHICH MAY REGULATE HNF1? AND CELL SURVIVAL, IN OVARIAN CLEAR CELL CARCINOMA
(CCC)
Congress
|
ESGO 2013 |
2013 - 2013 | GLUTAMINE AND CYSTEINE CONTRIBUTE FOR OVARIAN CLEAR CELL CARCINOMA SURVIVAL (OCCC), THROUGH mTOR ACTIVATION AND GLUTATHIONE
SYNTHESIS
Congress
|
ESGO 2013 |
2013 - 2013 | PRODUCTION AND CONSUMPTION OF LACTATE IS RELATED TO THE HISTOLOGICAL TYPE IN UTERINE CERVIX CARCINOMAS
Congress
|
ESGO 2013 |
2013 - 2013 | ROLE OF SODIUM LACTATE (NALAC), C-MYC AND STAT3 IN THE METABOLIC SWITCH IN UTERINE CERVIX CARCINOMAS
Congress
|
Porto Cancer Meeting 2013 |
2012 - 2012 | Role of sodium lactate (NaLac), EGF and c-Myc in the expression of Monocarboxylated Transporter 1 (MCT1) in uterine cervix
cancer.
Congress
|
EACR one-day-meeting sponsored by Carlos Caldas |
2012 - 2012 | Fibronectin overexpression is associated to a more aggressive phenotype- in vitro and in vivo colon cancer models
Congress
|
EACR one-day-meeting sponsored by Carlos Caldas |
2011 - 2011 | Monocarboxylate transporters (MCTs) and lactate dehydrogenases (LDHs) as putative therapeutic targets in acute myeloid leukaemia
(AML)
Congress
|
Experimental Biology 2011 |
2011 - 2011 | Metabolic adaptation of uterine cervix cancer cells- in vitro and in vivo models (2011).
Congress
|
TUMIC meeting |
2010 - 2010 | Role of VEGF signalling in the regulation of KDR expression, in endothelial and tumoural microenvironment
Congress
|
16th International Charles Heidelberger Symposium on Cancer Research |
2010 - 2010 | CELL DEATH INDUCED BY HDACS INHIBITORS IN OVARIAN CANCER CELL LINES (SEROUS AND CLEAR CELL CARCINOMAS) - ROLE OF NOTCH, TP53
AND FN1
Congress
|
16th International Charles Heidelberger Symposium on Cancer Research |
2009 - 2009 | Colon cancer cells that metabolise butyrte acquire EMT phenotypes including increased tumour growth, angiogenesis and metastasis
Congress
|
Metastasis Summer School, Sesimbra, Portugal and Fifth international conference on tumor microenvironment: progression, therapy, and prevention |
2008 - 2008 | Butyric acid induces a more aggressive phenotype in HCT15 colon cancer cells, in vitro and in vivo studies.
Congress
|
12ª reunião da Sociedade Portuguesa de Genética Humana |
2007 - 2007 | Butyric acid treatment of resistant colon cancer cells promotes the acquisition of a more angiogenic phenotype
Congress
|
ELSO 2007 |
2005 - 2005 | Overexpression of Lea and Lewis enzyme in gastric cancer cell lines and in gastric tissues is related to DNA hypomethylation
Congress
|
96th AACR-2005 |
2004 - 2004 | Two new FUT2 missense polymorphisms, 739G>A and 839T>C, are partly responsible for non-secretor status in a Caucasian population
from Northern Portugal
Congress
|
EACR-18. |
2004 - 2004 | Two new FUT2 missense polymorphisms, 739G>A and 839T>C, are partly responsible for non-secretor status in a Caucasian population
from Northern Portugal
Congress
|
GlycoT 2004 |
2003 - 2003 | Regulation of expression of alpha-1,4 fucosyltransferases (FUT3 and FUT5) and Lewis antigens by promoter methylation in gastric
carcinoma cell lines.
Congress
|
Mucins in Health and Disease – 7th International Workshop on Carcinoma-associated mucins |
2002 - 2002 | Polymorphisms of Lewis enzyme (alpha 1-3/4 fucosyltransferase) and study of its relationship with Helicobacter pylori infection
in a portuguese population
Congress
|
Congresso ELSO (European Life Scientist Organization) |
2000 - 2000 | Biosynthetic pathway of type 1 chain Lewis antigens in MUC5AC and MUC2 expressing cells of intestinal metaplasia
Congress
|
EU Consortium Meeting - Mucins in the pathophysiology of inflammatory diseases of the respiratory and digestive tract |
1999 - 1999 | Deteccção de dsRNA de vírus delevedura utilizando uma biblioteca de péptidos expressa em fagos
Congress
|
National Congress of Microbiology- Micro 99 |
1998 - 1998 | Construction of a Vaccinium myrtillus cDNA library and screening for exoperoxidases genes
Congress
|
National Congress of Biochemistry |
1998 - 1998 | Selection of phage-peptides with affinity for dsRNA from a 15-MER phage display peptide library
Congress
|
National Congress of Biochemistry |
1998 - 1998 | Production of recombinant antibodies against dsRNA
Congress
|
National Congress of Biochemistry |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2024/09/15 - 2024/12/20 | 5th Edition- Graduation in genetics and genomics in clinics (GGGC) | Graduation in genetics and genomics in clinics (GGGC) (Pós-Graduação) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
2023/09/15 - 2023/12/21 | 4th Edition- Graduation in genetics and genomics in clinics (GGGC) | Graduation in genetics and genomics in clinics (GGGC) (Pós-Graduação) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
2022/09/14 - 2022/12/21 | 3rd Edition- Graduation in genetics and genomics in clinics (GGGC) | Graduation in genetics and genomics in clinics (GGGC) (Pós-Graduação) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
2021/09/13 - 2021/12/20 | 2nd Edition- Graduation in genetics and genomics in clinics (GGGC) | Graduation in genetics and genomics in clinics (GGGC) (Pós-Graduação) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
2020/09/13 - 2021/02/06 | 1st Edition- Graduation in genetics and genomics in clinics (GGGC) | Graduation in genetics and genomics in clinics (GGGC) (Pós-Graduação) | Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal |
Distinctions
Other distinction
2008 | Prémio BLPCC (Bolsa da Liga Portuguesa Contra o Cancro)
Liga Portuguesa Contra o Cancro, Portugal
|